Maximus - MMS Stock Forecast, Price & News

Maximus' stock was trading at $73.33 at the start of the year. Since then, MMS shares have increased by 3.1% and is now trading at $75.58.
View the best growth stocks for 2023 here.

Maximus saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 1,320,000 shares, a decline of 33.0% from the December 31st total of 1,970,000 shares. Based on an average trading volume of 386,700 shares, the days-to-cover ratio is currently 3.4 days. Approximately 2.2% of the shares of the stock are short sold.
View Maximus' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023.
View our MMS earnings forecast.

Maximus will be holding an earnings conference call on Thursday, February 9th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Maximus, Inc. (NYSE:MMS) issued its earnings results on Monday, November, 21st. The health services provider reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.38. The health services provider had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.09 billion. Maximus had a net margin of 4.40% and a trailing twelve-month return on equity of 17.59%.

Maximus announced a quarterly dividend on Tuesday, January 10th. Shareholders of record on Wednesday, February 15th will be paid a dividend of $0.28 per share on Tuesday, February 28th. This represents a $1.12 annualized dividend and a dividend yield of 1.48%. The ex-dividend date is Tuesday, February 14th.
Read our dividend analysis for MMS.

Maximus (NYSE:MMS) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.49%. The dividend payout ratio is 34.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 25.93% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

Maximus issued an update on its FY23 earnings guidance on Wednesday, February, 8th. The company provided EPS guidance of $4.00-4.30 for the period, compared to the consensus earnings per share estimate of $3.83. The company issued revenue guidance of $4.85-5.00 billion, compared to the consensus revenue estimate of $4.77 billion.

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Maximus' stock is owned by many different institutional and retail investors. Top institutional shareholders include Mondrian Investment Partners LTD (1.91%), Allspring Global Investments Holdings LLC (1.25%), Thrivent Financial for Lutherans (1.05%), Vaughan Nelson Investment Management L.P. (0.90%), Stephens Investment Management Group LLC (0.42%) and Reinhart Partners Inc. (0.40%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau, Teresa Weipert, Thomas D Romeo and Thomas D Romeo.
View institutional ownership trends.

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMS stock can currently be purchased for approximately $75.58.

Maximus (NYSE:MMS) has a market capitalization of $4.59 billion and generates $4.63 billion in revenue each year. The health services provider earns $203.83 million in net income (profit) each year or $3.29 on an earnings per share basis.

The company employs 39,500 workers across the globe.

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The official website for the company is www.maximus.com. The health services provider can be reached via phone at (703) 251-8500, via email at investorrelations@maximus.com, or via fax at 703-251-8240.